DM-204

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameDM-204
Drug Alias Nameanti-GSK-3beta mAbs (Sanomune)anti-GSK-3beta monoclonal antibodies (Sanomune)anti-GSK-3beta monoclonal antibodies (DiaMedica)anti-GSK-3beta mAbs (DiaMedica)DM-204
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody murine
Mechanisms of ActionBradykinin B2 receptor agonistsGlycogen synthase kinase-3 beta inhibitors
TargetsBradykinin B2 receptorGlycogen synthase kinase-3 beta
Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes MellitusHypertension +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSanomune Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanomune IncDiamedica Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2Diabetes MellitusHypertension +[7] 

Other Information

ATC CodeN/A
Related LinksN/A